Latest Strategic Planning News

Lotus Resources has achieved a pivotal milestone by producing its first yellowcake at the Kayelekera Uranium Mine, marking its emergence as a global uranium producer. The company targets ramping up production to 200,000 pounds per month by early 2026.

InFocus Group Holdings reported a 5.3% revenue increase for FY2025 but also a nearly 20% rise in net losses, alongside a sharp drop in net tangible assets per share.

Jayride Group Limited revealed a 55.5% plunge in revenue to $2.42 million for the fiscal year ending June 2025, alongside a reduced net loss of $5.7 million, signaling some financial stabilization despite ongoing challenges.

Jatcorp Limited reported a $6.9 million net loss for FY25, hit by a trademark dispute in China that suspended key product sales. Despite setbacks, the company is accelerating new channel growth and product innovation to regain momentum.

PainChek Limited reported a 24% revenue increase to $4.8 million for FY25, narrowing its net loss by 7%, while progressing toward FDA clearance for its Adult PainChek App in the US and launching its Infant App in Australia.

Rectifier Technologies Ltd reported a significant downturn in FY2025, with revenues falling 30.8% and a shift from profit to loss driven by a global EV market slowdown. The company is responding with cost controls and strategic pivots toward clean energy integration.

Webjet Group Limited reported steady FY25 EBITDA of $51.6 million, buoyed by rising international bookings despite domestic softness, and unveiled an ambitious FY30 strategy including the acquisition of Locomote to expand its business travel footprint.

Orcoda Limited faced a challenging FY25 due to delayed projects from a key customer but is poised for recovery with new contracts and growth in recurring revenue. The company’s strategic diversification and AI-powered solutions underpin a confident outlook for FY26.

Orcoda Limited reported a 33% drop in FY25 revenue to $17.16 million and a net loss of $2.5 million, driven by deferred projects in its Resource & Infrastructure division. Meanwhile, its Transport Technology division posted EBITDA growth, signaling a potential turnaround.

Nuchev Limited reported a strong FY25 with revenue doubling to $22.9 million, driven by growth in Oli6® Nutritionals and the integration of bWellness Practitioner channel. Adjusted EBITDA loss narrowed significantly amid improved margins and cost control.

Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.